{"id":111688,"date":"2026-08-26T18:42:18","date_gmt":"2026-08-26T18:42:18","guid":{"rendered":"https:\/\/www.europesays.com\/britain\/111688\/"},"modified":"2026-08-26T18:42:18","modified_gmt":"2026-08-26T18:42:18","slug":"pharmalittle-shingles-shot-cuts-heart-risk-mass-biotech-jobs-drop","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/britain\/111688\/","title":{"rendered":"Pharmalittle: Shingles shot cuts heart risk, Mass. biotech jobs drop"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a needed cup of stimulation. Our choice today is ginseng honey, a favorite from our pantry. Meanwhile, here is the latest menu of tidbits to help you on your way. We hope you conquer the world and have a wonderful day. And as always, please do stay in touch. \u2026<\/p>\n<p class=\"wp-block-paragraph\">About 14% of employers in the U.S. have already or plan to drop coverage of GLP-1 drugs in 2027, as companies see \u200brising health care costs, <a href=\"https:\/\/www.reuters.com\/legal\/litigation\/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25\/\" id=\"https:\/\/www.reuters.com\/legal\/litigation\/more-us-employers-drop-weight-loss-drugs-2027-healthcare-costs-increase-2026-08-25\/\" target=\"_blank\" rel=\"noopener nofollow\">Reuters<\/a> notes, citing a <a href=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/2027_HCS_Survey-ES-FINAL.pdf\" id=\"https:\/\/www.statnews.com\/wp-content\/uploads\/2026\/08\/2027_HCS_Survey-ES-FINAL.pdf\" rel=\"nofollow noopener\" target=\"_blank\">survey<\/a> by the Business Group \u200con Health. \u00a0Two-thirds of employers reported rising use of \u200bthe medicines while the share of employers \u200bcovering GLP-1 weight loss \u2060drugs dropped from 72% in 2025 to 60% in 2026. Pharmacy costs made up 25% of employer health care spending and are expected to rise by 12% in 2027, unchanged from the \u200byear prior. PepsiCo, for example, is dropping coverage, says <a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2026-08-25\/pepsico-scraps-coverage-of-weight-loss-drugs-for-employees\" id=\"https:\/\/www.bloomberg.com\/news\/articles\/2026-08-25\/pepsico-scraps-coverage-of-weight-loss-drugs-for-employees\" target=\"_blank\" rel=\"noopener nofollow\">Bloomberg News<\/a>.<\/p>\n<p class=\"wp-block-paragraph\">The number of people working in Massachusetts\u2019 renowned\u00a0biotech sector\u00a0fell last year, the first time that\u2019s happened since at least 2002, <a href=\"https:\/\/www.statnews.com\/2026\/08\/25\/massachusetts-biotech-slump-then-turnaround\/\" id=\"https:\/\/www.statnews.com\/2026\/08\/25\/massachusetts-biotech-slump-then-turnaround\/\" rel=\"nofollow noopener\" target=\"_blank\">The Boston Globe<\/a> writes. The state\u2019s biopharma workforce shrank by about 3,600 employees in 2025, to a total of 113,503, as industry headwinds and uncertainty about federal funding for scientific research battered the sector, according to the annual \u201c<a href=\"https:\/\/www.massbio.org\/wp-content\/uploads\/2026\/08\/2026_MassBio_IndustrySnapshot_Final.pdf\" id=\"https:\/\/www.massbio.org\/wp-content\/uploads\/2026\/08\/2026_MassBio_IndustrySnapshot_Final.pdf\" target=\"_blank\" rel=\"noopener nofollow\">industry snapshot<\/a>\u201d by the Massachusetts Biotechnology Council trade group. Compared to 2024, the workforce declined by 3.1%.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.europesays.com\/britain\/wp-content\/uploads\/2026\/05\/stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and&hellip;\n","protected":false},"author":2,"featured_media":50049,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[20784],"tags":[20785,25092,20102],"class_list":["post-111688","post","type-post","status-publish","format-standard","has-post-thumbnail","category-gsk","tag-gsk","tag-pharmalittle","tag-stat"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@UnitedKingdom\/117163284575553849","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/111688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/comments?post=111688"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/posts\/111688\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media\/50049"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/media?parent=111688"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/categories?post=111688"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/britain\/wp-json\/wp\/v2\/tags?post=111688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}